I agree that this site is using cookies. You can find further informations here.
X
Tylki-Szymańska, A.
334  results:
Search for persons X
?
1

Efficacité à long terme du traitement par velmanase alfa ch..:

Guffon, N. ; Borgwardt, L. ; Tylki-Szymańska, A....
La Revue de Médecine Interne.  45 (2024)  - p. A90-A91 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Audiological and radiological study of eight polish patient..:

Iwanicka-Pronicka, K. ; Guzek, A. ; Sarnecki, J..
International Journal of Pediatric Otorhinolaryngology.  169 (2023)  - p. 111556 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Transformative effect of a Humanitarian Program for individ..:

Verma, I. C. ; El-Beshlawy, A. ; Tylki-Szymańska, A....
Orphanet Journal of Rare Diseases.  17 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
4

Recognition of alpha-mannosidosis in paediatric and adult p..:

Guffon, N. ; Tylki-Szymanska, A. ; Borgwardt, L....
Molecular Genetics and Metabolism.  126 (2019)  4 - p. 470-474 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Management goals for type 1 Gaucher disease: An expert cons..:

Biegstraaten, M. ; Cox, T.M. ; Belmatoug, N....
Blood Cells, Molecules, and Diseases.  68 (2018)  - p. 203-208 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Benefit of Sebelipase Alfa in Children and Adults with Lyso..:

Abel, F. ; Arnoux, J.-B. ; Kostyleva, M....
Journal of Hepatology.  64 (2016)  2 - p. S298-S299 , 2016
Link: https://doi.org/10.1016/..
 
?
7

Osteoimmunology in mucopolysaccharidoses type I, II, VI and..:

Opoka-Winiarska, V. ; Jurecka, A. ; Emeryk, A..
Osteoarthritis and Cartilage.  21 (2013)  12 - p. 1813-1823 , 2013
Link: https://doi.org/10.1016/..
 
?
8

Nephrological abnormalities in patients with transaldolase ..:

Loeffen, Y. G. T. ; Biebuyck, N. ; Wamelink, M. M. C....
Nephrology Dialysis Transplantation.  27 (2012)  8 - p. 3224-3227 , 2012
Link: https://doi.org/10.1093/..
 
?
9

P23—New Guidelines for the Evaluation and Management of Fab..:

Tylki-Szymanska, A. ; Hopkin, R.J. ; Banikazemi, M....
Clinical Therapeutics.  34 (2012)  4 - p. e27 , 2012
Link: https://doi.org/10.1016/..
 
?
10

Saposin C mutations in Gaucher disease patients resulting i..:

Vaccaro, A. M. ; Motta, M. ; Tatti, M....
Human Molecular Genetics.  19 (2010)  15 - p. 2987-2997 , 2010
Link: https://doi.org/10.1093/..
 
?
11

Female Hunter syndrome caused by a single mutation and fami..:

Kloska, A ; Jakóbkiewicz-Banecka, J ; Tylki-Szymańska, A..
Clinical Genetics.  80 (2010)  5 - p. 459-465 , 2010
Link: https://doi.org/10.1111/..
 
?
12

Adrenoleukodystrophy (X-ALD) – changes in serum VLCFA profi..:

Stradomska, T.J. ; Tylki-Szymańska, A.
European Journal of Paediatric Neurology.  12 (2008)  - p. S73-S74 , 2008
Link: https://doi.org/10.1016/..
 
?
13

How can we treat lysosomal disorders?:

Tylki-Szymańska, A.
European Journal of Paediatric Neurology.  12 (2008)  - p. S24 , 2008
Link: https://doi.org/10.1016/..
 
?
14

Diagnosis, characteristics and treatment of patients with a..:

Jurecka, A. ; Tylki-Szymańska, A. ; Bogdanska, A....
European Journal of Paediatric Neurology.  12 (2008)  - p. S64 , 2008
Link: https://doi.org/10.1016/..
 
?
15

Metachromatic leukodystrophy – a neurometabolic disorder of..:

Ługowska, A. ; Tylki-Szymańska, A.
European Journal of Paediatric Neurology.  12 (2008)  - p. S14-S15 , 2008
Link: https://doi.org/10.1016/..
 
1-15